Portola Pharma (PTLA) Granted Conditional Marketing Authorization for Ondexxya in Europe

Portola Pharma (PTLA) Granted Conditional Marketing Authorization for Ondexxya in Europe - StreetInsider.com

April 30, 2019

Portola Pharma (PTLA) Granted Conditional Marketing Authorization for Ondexxya in Europe StreetInsider.com

Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here. Portola Pharmaceuticals, Inc.® (Nasdaq: PTLA) ...

Signs of Pulmonary Embolism

Portola Pharma (PTLA) Granted Conditional Marketing Authorization for Ondexxya in Europe - StreetInsider.com

Comments

Post a Comment

Popular posts from this blog

Investigational oral contraceptive patch offers comparable safety to approved products - Healio

EMA imposes formal limit on Xeljanz prescription as regulators continue to review safety concerns - Endpoints News

What Caused Young IBD Patient's Headache and Right-Side Weakness? - MedPage Today